Oruka Therapeutics, Inc. ORKA Number of Vested and Expected to Vest Options
Number of Vested and Expected to Vest Options at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s number of vested and expected to vest options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s number of vested and expected to vest options?
- Oruka Therapeutics, Inc. (ORKA) reported number of vested and expected to vest options of 5.3M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s number of vested and expected to vest options changed year-over-year?
- Oruka Therapeutics, Inc.'s number of vested and expected to vest options increased by 62.2% year-over-year, from 3.3M to 5.3M.
- What does number of vested and expected to vest options mean?
- This metric quantifies the total number of share-based payment options that have either met their vesting requirements or are anticipated to vest based on service conditions. It is a key indicator of potential future dilution for shareholders and the company's long-term incentive structure for talent retention.